Circulation Research, Vol 72, 246-254, Copyright © 1993 by American Heart Association
ARTICLES |
JD Roberts Jr, TY Chen, N Kawai, J Wain, P Dupuy, A Shimouchi, K Bloch, D Polaner and WM Zapol
Department of Anaesthesia, Harvard Medical School, Massachusetts General Hospital, Boston 02114.
We determined whether inhaling low levels of nitric oxide (NO) gas could selectively reverse hypoxic pulmonary vasoconstriction in the near-term newborn lamb and whether vasodilation would be attenuated by respiratory acidosis. To examine the mechanism of air and NO-induced pulmonary vasodilation soon after birth, we measured plasma and lung cGMP levels in the newly ventilated fetal lamb. Breathing at FIO2 0.10 nearly doubled the pulmonary vascular resistance index in newborn lambs and decreased pulmonary blood flow primarily by reducing left-to-right blood flow through the ductus arteriosus. Inhaling 20 ppm NO at FIO2 0.10 completely reversed hypoxic pulmonary vasoconstriction within minutes. Maximum pulmonary vasodilation occurred during inhalation of > or = 80 ppm NO. Breathing 8% CO2 at FIO2 0.10 elevated the pulmonary vascular resistance index to a level similar to breathing at FIO2 0.10 without added CO2. Respiratory acidosis did not attenuate pulmonary vasodilation by inhaled NO. In none of our studies did inhaling NO produce systemic hypotension or elevate methemoglobin levels. Four minutes after initiating ventilation with air in the fetal lamb lung, cGMP concentration nearly doubled without changing preductal plasma cGMP concentration. Ventilation with 80 ppm NO at FIO2 0.21 increased both lung and preductal plasma cGMP concentration threefold. Our data suggest that inhaled NO gas is a rapid and potent selective vasodilator of the newborn pulmonary circulation with an elevated vascular tone due to hypoxia and respiratory acidosis that acts by increasing lung cGMP concentration.
This article has been cited by other articles:
![]() |
P. Fesler, A. Pagnamenta, B. Rondelet, F. Kerbaul, and R. Naeije Effects of sildenafil on hypoxic pulmonary vascular function in dogs J Appl Physiol, October 1, 2006; 101(4): 1085 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Journois, C. Baufreton, P. Mauriat, P. Pouard, P. Vouhe, and D. Safran Effects of Inhaled Nitric Oxide Administration on Early Postoperative Mortality in Patients Operated for Correction of Atrioventricular Canal Defects Chest, November 1, 2005; 128(5): 3537 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Deruelle, T. R. Grover, and S. H. Abman Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L798 - L806. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Bland, K. H. Albertine, D. P. Carlton, and A. J. MacRitchie Inhaled Nitric Oxide Effects on Lung Structure and Function in Chronically Ventilated Preterm Lambs Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 899 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Bland, C. Y. Ling, K. H. Albertine, D. P. Carlton, A. J. MacRitchie, R. W. Day, and M. J. Dahl Pulmonary vascular dysfunction in preterm lambs with chronic lung disease Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L76 - L85. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. MacRitchie, K. H. Albertine, J. Sun, P. S. Lei, S. C. Jensen, A. A. Freestone, P. M. Clair, M. J. Dahl, E. A. Godfrey, D. P. Carlton, et al. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L1011 - L1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nie, H. Kobayashi, M. Sugawara, T. Tomita, K. Ohara, and H. Yoshimura Helium inhalation enhances vasodilator effect of inhaled nitric oxide on pulmonary vessels in hypoxic dogs Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1875 - H1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Roberts Jr, J.-D. Chiche, J. Weimann, W. Steudel, W. M. Zapol, and K. D. Bloch Nitric Oxide Inhalation Decreases Pulmonary Artery Remodeling in the Injured Lungs of Rat Pups Circ. Res., July 21, 2000; 87(2): 140 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kinsella Clinical Trials of Inhaled Nitric Oxide Therapy in the Newborn Pediatr. Rev., November 1, 1999; 20(11): e110 - e113. [Full Text] [PDF] |
||||
![]() |
R. D. Bland Inhaled Nitric Oxide: A Premature Remedy for Chronic Lung Disease? Pediatrics, March 1, 1999; 103(3): 667 - 669. [Full Text] |
||||
![]() |
J. W. ZIEGLER, D. D. IVY, J. W. WIGGINS, J. P. KINSELLA, W. R. CLARKE, and S. H. ABMAN Effects of Dipyridamole and Inhaled Nitric Oxide in Pediatric Patients with Pulmonary Hypertension Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1388 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. HANSON, F. BURNS, S. D. RYBALKIN, J. W. MILLER, J. BEAVO, and W. R. CLARKE Developmental Changes in Lung cGMP Phosphodiesterase-5 Activity, Protein, and Message Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 279 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gries, C. Bode, K. Peter, A. Herr, H. Bohrer, J. Motsch, and E. Martin Inhaled Nitric Oxide Inhibits Human Platelet Aggregation, P-Selectin Expression, and Fibrinogen Binding In Vitro and In Vivo Circulation, April 21, 1998; 97(15): 1481 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Davidson, E. S. Barefield, J. Kattwinkel, G. Dudell, M. Damask, R. Straube, J. Rhines, C.-T. Chang, and the I-NO/PPHN Study Group Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study Pediatrics, March 1, 1998; 101(3): 325 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fouty, P. Komalavilas, M. Muramatsu, A. Cohen, I. F. McMurtry, T. M. Lincoln, and D. M. Rodman Protein kinase G is not essential to NO-cGMP modulation of basal tone in rat pulmonary circulation Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H672 - H678. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. M. N. Quezado, C. Natanson, W. Karzai, R. L. Danner, C. A. Koev, Y. Fitz, D. P. Dolan, S. Richmond, S. M. Banks, L. Wilson, et al. Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis J Appl Physiol, January 1, 1998; 84(1): 107 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Brilli, B. Krafte-Jacobs, D. J. Smith, D. Roselle, D. Passerini, A. Vromen, L. Moore, C. Szabo, and A. L. Salzman Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension J Appl Physiol, December 1, 1997; 83(6): 1968 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Fisher and S. C. Body Physiology of One-Lung Ventilation Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1997; 1(3): 236 - 255. [Abstract] [PDF] |
||||
![]() |
N. Finer Inhaled Nitric Oxide and Hypoxic Respiratory Failure in Infants With Congenital Diaphragmatic Hernia Pediatrics, June 1, 1997; 99(6): 838 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mathew, E. S. Gloster, T. Sundararajan, C. I. Thompson, G. A. Zeballos, and M. H. Gewitz Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension J Appl Physiol, May 1, 1997; 82(5): 1493 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gamillscheg, G. Zobel, B. Urlesberger, J. Berger, D. Dacar, J. I. Stein, B. Rigler, H. Metzler, and A. Beitzke INHALED NITRIC OXIDE IN PATIENTS WITH CRITICAL PULMONARY PERFUSION AFTER FONTAN-TYPE PROCEDURES AND BIDIRECTIONAL GLENN ANASTOMOSIS J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 435 - 442. [Abstract] [Full Text] |
||||
![]() |
H. Aly, R. Sahni, and J.-T. Wung Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn Arch. Dis. Child. Fetal Neonatal Ed., March 1, 1997; 76(2): 118F - 122. [Abstract] [Full Text] |
||||
![]() |
The Neonatal Inhaled Nitric Oxide Study Group Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure N. Engl. J. Med., February 27, 1997; 336(9): 597 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Roberts, J. R. Fineman, F. C. Morin, P. W. Shaul, S. Rimar, M. D. Schreiber, R. A. Polin, M. S. Zwass, M. M. Zayek, I. Gross, et al. Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn N. Engl. J. Med., February 27, 1997; 336(9): 605 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Lee, C. Adrie, H. J. Jacob, J. D. Roberts Jr, W. M. Zapol, and K. D. Bloch Chronic Inhalation of Nitric Oxide Inhibits Neointimal Formation After Balloon-Induced Arterial Injury Circ. Res., February 1, 1996; 78(2): 337 - 342. [Abstract] [Full Text] |
||||
![]() |
W. J. Fulkerson, N. MacIntyre, J. Stamler, and J. D. Crapo Pathogenesis and Treatment of the Adult Respiratory Distress Syndrome Arch Intern Med, January 8, 1996; 156(1): 29 - 38. [Abstract] [PDF] |
||||
![]() |
J. D. Roberts Jr, C. T. Roberts, R. C. Jones, W. M. Zapol, and K. D. Bloch Continuous Nitric Oxide Inhalation Reduces Pulmonary Arterial Structural Changes, Right Ventricular Hypertrophy, and Growth Retardation in the Hypoxic Newborn Rat Circ. Res., February 1, 1995; 76(2): 215 - 222. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |